Multi-criteria decision making of COVID-19 vaccines (in India) based on ranking interpreter technique under single valued bipolar neutrosophic environment

基于单值双极中智环境下排序解释器技术的COVID-19疫苗(印度)多准则决策

阅读:1

Abstract

COVID-19 is a respiratory infection caused by a coronavirus that spreads from person to person. In the present situation, the COVID-19 pandemic is a swiftly rising phase. Now the time is the second wave ending phase of coronavirus and the third wave coming phase of coronavirus in India. The pandemic situation is moving forward all over India. Nowadays, the worldwide COVID-19 pandemic structure is a very hazardous situation. The COVID-19 vaccine can suppress this situation and gain preventive measures against coronavirus. In producing the COVID-19 vaccine, the Indian medical board plays a significant role. The COVID-19 vaccines have exhibited 90%-95% efficacy in preventing symptomatic COVID-19 infections. Against COVID-19, for emergency purposes, the Indian medical board has approved three vaccines: Covishield, Covaxin, and Sputnik V. Generally, the Indian people are embarrassed about the vaccination of COVID-19. All people are thinking about which vaccine is best for them. This labyrinth can be evaluated effectively using the multi-criteria decision-making (MCDM) technique. Therefore, we have proposed a novel MCDM technique for selecting COVID-19 vaccines. The main aim of this paper is to develop an MCDM technique based on a λ -weighted ranking interpreter ( Rλ+, Rλ- ). The first time, we have defined positive and negative λ -weighted rank interpreter for the ranking of single-valued bipolar neutrosophic (SVbN) number. Additionally, positive and negative λ -weighted values and positive and negative λ -weighted ambiguity of an SVbN-number are formulated here. Some important, valuable theorems and corollary of SVbN-number are formulated. To show the applicability of the proposed MCDM technique, we have considered a real decision-making problem where ratings of the alternatives are with SVbN-numbers.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。